Skip to main content

Biosimilar switching in practice Hyrich: UK experience Switching to biosimilar has no immediate benefit to patients but

Social Author Name
Eric Dein
Tweet Content
Biosimilar switching in practice Hyrich: UK experience Switching to biosimilar has no immediate benefit to patients but saves NHS money Allows for gain share that can be re-invested in pt care Transparency in switching in explaining to pts and offering resource @RheumNow #ACR24
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×